Image

Global Tissue Regeneration Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Jul 2022
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Tissue Regeneration Market, By Technology (Cell Therapy, Stem Cell Therapy, Stem Cell Sources, Tissue Vascularization, Cell Culturing and Others), Raw Material (Synthetic, Genetically modified and Biological), Application (Cardiovascular, Oncology, Dermatology, Orthopedic, Neurology, Ophthalmology and Others), End-User (Hospital & Diagnostic Centres, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Others) – Industry Trends and Forecast to 2029

Tissue Regeneration Market

Market Analysis and Size

Congenital illnesses, malformations, and disease-related tissue damage drive the demand for tissue regeneration. This factor is expected to shape the future trajectory of the global tissue regeneration market in the coming years. Tissue engineering is essentially a procedure for controlling, repairing, and improving the function of injured tissue. The tissue regeneration technique increases a patient's life expectancy by repairing diseased or damaged organs, such as the kidneys. Regenerative medicine has the potential to address the current organ donor shortage; for example, tissue reengineered skin is extremely useful for foot and leg ulcers, burn wounds, and skin replacement.

Data Bridge Market Research analyses that the tissue regeneration market is expected to reach the value of USD 482.95 billion by the year 2029, at a CAGR of 25.44% during the forecast period. The growing demand for personalised medicines will aid in the expansion of the tissue regeneration market.

Market Definition

Tissue regeneration is the process of restoring or repairing damaged or diseased tissue by regrowing or replacing it. Congenital diseases, defects, and tissue damage caused by diseases promote the need for tissue regeneration. This technique includes a tissue engineering procedure that manages, restores, and improves the application of damaged tissue. The tissue regeneration procedure increases patients' life expectancy by restoring damaged organs, including the kidneys. Regenerative medicine has the potential to end the current shortage of organ donors; for example, tissue reengineered skin is extremely beneficial for skin replacement, burn wounds, and ulcers that affect the leg and foot.

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Technology (Cell Therapy, Stem Cell Therapy, Stem Cell Sources, Tissue Vascularization, Cell Culturing and Others), Raw Material (Synthetic, Genetically modified and Biological), Application (Cardiovascular, Oncology, Dermatology, Orthopedic, Neurology, Ophthalmology and Others), End-User (Hospital & Diagnostic Centres, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Others

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

 

 

 

 

 

 

 

 

 

 

Oppurtunities

Arteriocyte Medical Systems Inc. (U.S.), Athersys Inc. (U.S.), Cerapedics Inc. (U.S.), Co. Don AG (Germany), Cook Medical Inc. (U.S.), U.S. Stem Cell Inc. (U.S.), Cytori Therapeutics, Inc. (U.S.A), Cerapedicsm, Inc. (U.S.), Organogenesis, Inc. (U.S.), Wright Medical Group N.V. (Netherlands), Zimmer Biomet (U.S), ACell, Inc. (U.S.), Tissue Regenix (U.S.)

 

 

 

  • The rising prevalence of chronic diseases
  • the use of biomarkers in disease diagnosis
  • the need for personalised medicines, and government grants and investments around the world

Tissue regeneration Market Dynamics

Drivers

  • The rise in the use biomarkers

The rising prevalence of chronic diseases, the use of biomarkers in disease diagnosis, the need for personalised medicines, and government grants and investments around the world are expected to drive the growth of the tissue regeneration market.

The increase in the use of 3d printing functions

The expansion of 3D printing functions in tissue regeneration, as a result of research and development and invention in biomaterials, nanotechnology, cell therapies, and drug delivery, is expected to amplify the growth of the tissue regeneration market during the forecast period.

Regulatory Compliance

Maintaining compliance with medical reforms and regulations raises the demand for these solutions.

  • Government investments for healthcare interoperability

The increase in the funding by the federal government to drive the adoption of these solutions further influence the market. Additionally, the surge in healthcare expenditure, advancements in healthcare infrastructure, and high demand for expanded care delivery positively affect the tissue regeneration market.

.Restraints/Challenges

Strict government administrations, repayment concerns, particularly in emerging nations, and less funding in developing countries are the factors most likely to stymie the growth of the tissue regeneration market.

This tissue regeneration market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the tissue regeneration market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Tissue Regeneration Market

The pandemic of COVID-19 has had a significant impact on the health-care industry. Since the COVID 19 pandemic, clinical tissue engineering research has been made unavailable, and non-COVID 19 clinical trials have been reduced. In the meantime, several pharmaceutical and biotech companies have shifted their focus to the development of COVID-19 treatment drugs and vaccines. Furthermore, a significant decrease in cell and tissue donation programmes has restrained the global tissue engineering market. As a result, clinical research delays and disruptions, as well as cancellations or delays in tissue replacement and reconstructive procedures, impede the global tissue engineering market's growth.

Recent Development

  • The United States Department of Health launched the "New Vision" initiative in 2020 with the goal of bringing regenerative medicine and stem cell therapy to the forefront of healthcare.
  • Tissue Regeneration Technologies (TRT) announced an important addition to our patent family in April 2020, which could aid in the fight against the Coronavirus. This patent employs the well-known mechanisms of action of unfocused shockwaves to combat this lethal virus.
  • ACell received an additional 510(k) FDA clearance for its Gentrix product line in April 2019. As a result, the indications for using the company's Gentrix surgical matrix products grew.

Global Tissue Regeneration Market Scope

The tissue regeneration market is segmented on the basis technology, raw material, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Technology

  • Cell therapy
  • Stem cell therapy
  • Stem cell sources
  • Tissue vascularization
  • Cell culturing
  • Others

Based on the technology, the tissue regeneration market is segmented into cell therapy, stem cell therapy, stem cell sources, tissue vascularization, cell culturing and others.

Raw material                                                                     

  • Synthetic
  • Genetically modified
  • Biological

Based on the raw material, the tissue regeneration market is segmented into synthetic, genetically modified and biological.

Application 

  • Cardiovascular
  • Oncology
  • Dermatology
  • Orthopaedic
  • Neurology
  • Ophthalmology
  • Others

Based on the application, the tissue regeneration market is segmented into cardiovascular, oncology, dermatology, orthopaedic, neurology, ophthalmology and others.

End User

  • Pharmaceutical biotechnology
  • Contract research organizations
  • Hospitals and diagnostics centres
  • Others

Based on the end-user, the tissue regeneration market is segmented into hospital and diagnostic centres, pharmaceutical and biotechnology companies, contract research organizations and others.

Tissue Regeneration Market Regional Analysis/Insights

The tissue regeneration market is analysed and market size insights and trends are provided by country, technology, raw material, application and end-user as referenced above.

The countries covered in the tissue regeneration market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the tissue regeneration market due to an ageing population and the availability of developed healthcare equipment. Factors such as an increase in the number of clinical trials to estimate product therapeutic potential, an increase in the incidence of chronic diseases, and an increase in public awareness of therapy's therapeutic potency are all driving the growth of the tissue regeneration market in the region. Europe is expected to see significant growth in the tissue regeneration market as a result of factors such as the easy availability of funds for R&D and the government's increasing support for the life science domain, which will further propel growth.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The tissue regeneration market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for tissue regeneration market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the tissue regeneration market. The data is available for historic period 2010-2020.

Competitive Landscape and Tissue Regeneration Market Share Analysis

The tissue regeneration market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to tissue regeneration market.

Some of the major players operating in the tissue regeneration market are

  • Arteriocyte Medical Systems Inc. (U.S.)
  • Athersys Inc. (U.S.)
  • Cerapedics Inc. (U.S.)
  • Co. Don AG (Germany)
  • Cook Medical Inc. (U.S.)
  • U.S. Stem Cell Inc. (U.S.)
  • Cytori Therapeutics, Inc. (U.S.A)
  • Cerapedicsm, Inc. (U.S.)
  • Organogenesis, Inc. (U.S.)
  • Wright Medical Group N.V. (Netherlands)
  • Zimmer Biomet (U.S)
  • ACell, Inc. (U.S.)
  • Tissue Regenix (U.S.)

Research Methodology: Global Tissue Regeneration Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions

On the basis of application, the Tissue Regeneration Market is segmented into Cardiovascular, Oncology, Dermatology, Orthopedic, Neurology, Opthalmology, Others.
The major players operating in the Tissue Regeneration Market are Arteriocyte Medical Systems Inc. (U.S.), Athersys Inc. (U.S.), Cerapedics Inc. (U.S.), Co. Don AG (Germany), Cook Medical Inc. (U.S.), U.S. Stem Cell Inc. (U.S.), Cytori Therapeutics, Inc. (U.S.A), Cerapedicsm, Inc. (U.S.), Organogenesis, Inc. (U.S.), Wright Medical Group N.V. (Netherlands), Zimmer Biomet (U.S), ACell, Inc. (U.S.), Tissue Regenix (U.S.).
On the basis of technology, the Tissue Regeneration Market is segmented into Cell Therapy, Stem Cell Therapy, Stem Cell Sources, Tissue Vascularization, Cell Culturing and Others.
On the basis of application, the Tissue Regeneration Market is segmented into Cardiovascular, Oncology, Dermatology, Orthopedic, Neurology, Ophthalmology and Others.